Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 31Carcinoma, Hepatocellular 30Neoplasms 19Carcinoma, Renal Cell 16Melanoma 10Carcinoma, Non-Small-Cell Lung 10Thyroid Neoplasms 9Endometrial Neoplasms 9Squamous Cell Carcinoma of Head and Neck 6Colorectal Neoplasms 5Triple Negative Breast Neoplasms 4Ovarian Neoplasms 4Neoplasm Metastasis 4Liver Neoplasms 4Carcinoma, Transitional Cell 4Uterine Cervical Neoplasms 3Small Cell Lung Carcinoma 3Recurrence 3Lymphoma 3Esophageal Squamous Cell Carcinoma 3Esophageal Neoplasms 3Carcinoma 3Biliary Tract Neoplasms 3Stomach Neoplasms 2Solid Tumors 2Osteosarcoma 2Lung Neoplasms 2Kidney Neoplasms 2Glioma 2Diabetes Mellitus, Insulin-Dependent, 12 2

Interventions

Carboplatin 98Pemetrexed 70pembrolizumab 68Cisplatin 59Paclitaxel 54Docetaxel 45Gemcitabine 37Erlotinib Hydrochloride 24Nivolumab 23osimertinib 17Bevacizumab 17durvalumab 14Cetuximab 13130-nm albumin-bound paclitaxel 13Gefitinib 11Etoposide 11Drug Therapy 11Ipilimumab 9Injections 9Albumin-Bound Paclitaxel 9Vinorelbine 8Radiotherapy 8motexafin gadolinium 7capmatinib 7atezolizumab 7epacadostat 6Taxes 6Cyclophosphamide 6vandetanib 5entinostat 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Lung Neoplasms × lenvatinib × Clear all
NCT01877083 2019-08-13

Study of the Safety and Activity of Lenvatinib (E7080) in Subjects With KIF5B-RET-Positive Adenocarcinoma of the Lung

Eisai Inc.

Phase 2 Completed
25 enrolled 11 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00832819 2015-04-30

E7080 in Combination With Carboplatin and Paclitaxel in Patients With Non-small Cell Lung Cancer (NSCLC)

Eisai Inc.

Phase 1 Completed
28 enrolled 8 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡